Chemoinformaics analysis of trans-6-Tridecene
| Molecular Weight | 182.351 | nRot | 9 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 1 |
| Exact Molecular Weight | 182.203 | nRing | 0 |
| Solubility: LogS | -6.448 | nHRing | 0 |
| Solubility: LogP | 6.284 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 39.0466 |
| nHD | 0 | BPOL | 26.0834 |
| QED | 0.344 |
| Synth | 1.921 |
| Natural Product Likeliness | 0.992 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.561 |
| MDCK | 0.0000154 |
| BBB | 0.365 |
| PPB | 0.992097 |
| VDSS | 4.777 |
| FU | 0.0162651 |
| CYP1A2-inh | 0.883 |
| CYP1A2-sub | 0.283 |
| CYP2c19-inh | 0.567 |
| CYP2c19-sub | 0.157 |
| CYP2c9-inh | 0.347 |
| CYP2c9-sub | 0.95 |
| CYP2d6-inh | 0.423 |
| CYP2d6-sub | 0.305 |
| CYP3a4-inh | 0.312 |
| CYP3a4-sub | 0.076 |
| CL | 3.245 |
| T12 | 0.425 |
| hERG | 0.092 |
| Ames | 0.003 |
| ROA | 0.024 |
| SkinSen | 0.933 |
| Carcinogencity | 0.039 |
| EI | 0.952 |
| Respiratory | 0.215 |
| NR-Aromatase | 0.018 |
| Antiviral | Yes |
| Prediction | 0.558128 |